Most cited papers from Kerckhoff Klinik

Kerckhoff Klinik

What are the most cited papers from Kerckhoff Klinik?

The most cited paper from Kerckhoff Klinik is "2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative" (Frank H J van den Hoogen et al., 2013), with 3,458 citations. Next come "ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation" (3,096) and "Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events" (2,837).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 58 papers. Every paper with more than 431 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative Frank H J van den Hoogen et al. · Arthritis & Rheumatism Open access	3 Oct 2013	3,458
2	ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Authors Task Force Members et al. · European Heart Journal Open access	26 Aug 2011	3,096
3	Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events Deepak L. Bhatt et al. · New England Journal of Medicine Open access	12 Mar 2006	2,837
4	2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension Marc Humbert et al. · European Respiratory Journal Open access	25 Aug 2022	2,235
5	CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells Volker Henn, Joseph R. Slupsky, Michael Gräfe et al. · Nature	Feb 1998	2,088
6	Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction Marc P. Bonaca et al. · New England Journal of Medicine Open access	14 Mar 2015	2,003
7	Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction Volker Schächinger, Sandra Erbs, Albrecht Elsässer et al. · New England Journal of Medicine Open access	21 Sep 2006	1,896
8	Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database A. J. Tyndall et al. · Annals of the Rheumatic Diseases Open access	15 Jun 2010	1,461
9	Association of Atrial Tissue Fibrosis Identified by Delayed Enhancement MRI and Atrial Fibrillation Catheter Ablation NASSIR F. MARROUCHE, David J. Wilber, Gerhard Hindricks et al. · JAMA	4 Feb 2014	1,449
10	Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension Hossein-Ardeschir Ghofrani, Andrea Maria D’Armini, Friedrich Grimminger et al. · New England Journal of Medicine Open access	24 Jul 2013	1,408
11	Circulating MicroRNAs in Patients With Coronary Artery Disease Stephan Fichtlscherer, Salvatore De Rosa, Henrik Fox et al. · Circulation Research Open access	Jul 2010	1,250
12	Ticagrelor with or without Aspirin in High-Risk Patients after PCI Roxana Mehran et al. · New England Journal of Medicine Open access	26 Sep 2019	1,040
13	European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring Gianfranco Parati et al. · Journal of Hypertension	30 May 2014	1,030
14	Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary Syndromes Stephan Ernst Baldus, Christopher Heeschen, Thomas Meinertz et al. · Circulation Open access	9 Sep 2003	1,018
15	Chronic thromboembolic pulmonary hypertension Nick H. Kim, Marion Delcroix, Xavier Jaïs et al. · European Respiratory Journal Open access	13 Dec 2018	1,016
16	Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database Ulrich Andreas Walker, Alan Tyndall, L. Czirják et al. · Annals of the Rheumatic Diseases Open access	18 Jan 2007	938
17	Transcatheter Aortic Valve Implantation in Failed Bioprosthetic Surgical Valves Danny Dvir et al. · JAMA Open access	8 Jul 2014	921
18	Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization Matthew T. Roe et al. · New England Journal of Medicine Open access	26 Aug 2012	884
19	Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events Deepak L. Bhatt et al. · New England Journal of Medicine Open access	10 Mar 2013	842
20	Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study Gerry Coghlan, Christopher P. Denton, Ekkehard Grünig et al. · Annals of the Rheumatic Diseases Open access	18 May 2013	838
21	Soluble CD40 Ligand in Acute Coronary Syndromes Christopher Heeschen, Stefanie Dimmeler, Christian W. Hamm et al. · New England Journal of Medicine Open access	19 Mar 2003	827
22	Patients With Prior Myocardial Infarction, Stroke, or Symptomatic Peripheral Arterial Disease in the CHARISMA Trial Deepak L. Bhatt et al. · Journal of the American College of Cardiology Open access	12 Apr 2007	804
23	Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial Karl‐Heinz Kück, Anselm Schaumann, Lars Eckardt et al. · The Lancet	2010	801
24	Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial Pascal Vranckx et al. · The Lancet Open access203 authors	27 Aug 2018	797
25	An Entirely Subcutaneous Implantable Cardioverter–Defibrillator Gust H. Bardy et al. · New England Journal of Medicine Open access	12 May 2010	782
26	Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials Mark Andrew Hlatky et al. · The Lancet	20 Mar 2009	745
27	Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin Ulrike Harre, Dan Georgess, Holger Bang et al. · Journal of Clinical Investigation Open access	16 Apr 2012	736
28	Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: Results from an international prospective registry Eckhard Mayer, David Paul Jenkins, Jaroslav Lindner et al. · Journal of Thoracic and Cardiovascular Surgery Open access	17 Feb 2011	734
29	Synovial fibroblasts spread rheumatoid arthritis to unaffected joints Stephanie Lefèvre, Anette Knedla, Christoph Tennie et al. · Nature Medicine Open access	8 Nov 2009	722
30	Mapping and predicting mortality from systemic sclerosis Muriel Elhaï et al. · Annals of the Rheumatic Diseases Open access	23 Aug 2017	707
31	Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial Dinesh Khanna et al. · The Lancet Open access	6 May 2016	686
32	MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial Juerg Schwitter, Christian M. Wacker, Albert C. van Rossum et al. · European Heart Journal Open access	21 Jan 2008	673
33	Prehospital Ticagrelor in ST-Segment Elevation Myocardial Infarction Gilles Montalescot et al. · New England Journal of Medicine Open access	Sep 2014	663
34	A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study Dae‐Hyun Yoo, Paweł Hrycaj, Pedro Cavaleiro Miranda et al. · Annals of the Rheumatic Diseases Open access	18 May 2013	655
35	Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine Michael A. Weber · Heart Open access	26 Oct 2005	625
36	EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR) Otylia Kowal‐Bielecka et al. · Annals of the Rheumatic Diseases Open access	15 Jan 2009	622
37	Validation of the Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio for the Assessment of Right Ventricular-Arterial Coupling in Severe Pulmonary Hypertension Khodr Tello, Jun Wan, Antonia Dalmer et al. · Circulation Cardiovascular Imaging Open access	Sep 2019	607
38	Left Ventricular Lead Position and Clinical Outcome in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT) Trial Jagmeet P. Singh, Helmut Klein, David Tsu-Chau Huang et al. · Circulation Open access	7 Mar 2011	593
39	ERS statement on chronic thromboembolic pulmonary hypertension Marion Delcroix et al. · European Respiratory Journal Open access	17 Dec 2020	583
40	EULAR definition of difficult-to-treat rheumatoid arthritis György Nagy et al. · Annals of the Rheumatic Diseases Open access	Oct 2020	570
41	Myocytes Die by Multiple Mechanisms in Failing Human Hearts Sawa Kostin, Lieven Pool, Albrecht Elsässer et al. · Circulation Research	17 Apr 2003	565
42	Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis Vanessa M. Smith et al. · Autoimmunity Reviews Open access	9 Jan 2020	531
43	Focused echocardiographic evaluation in life support and peri-resuscitation of emergency patients: A prospective trial Raoul Breitkreutz, Susanna Price, Holger V. Steiger et al. · Resuscitation	Sep 2010	518
44	Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban Christopher Heeschen, Christian W. Hamm, Britta U. Goldmann et al. · The Lancet	Nov 1999	516
45	Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial Arnoud W.J. van ’t Hof, Jurriën M. ten Berg, Ton A.A.C.M. Heestermans et al. · The Lancet	Aug 2008	513
46	Structural correlate of atrial fibrillation in human patients Sawa Kostin · Cardiovascular Research	May 2002	512
47	Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial Volker Schächinger et al. · European Heart Journal	13 Nov 2006	502
48	Bivalirudin Started during Emergency Transport for Primary PCI Philippe Gabríel Steg et al. · New England Journal of Medicine Open access	30 Oct 2013	499
49	Recombinant Hirudin (Lepirudin) Provides Safe and Effective Anticoagulation in Patients With Heparin-Induced Thrombocytopenia Andreas Greinacher, H. Völpel, Uwe Janssens et al. · Circulation Open access	12 Jan 1999	498
50	Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative Koen Visser et al. · Annals of the Rheumatic Diseases Open access	25 Nov 2008	493

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.